Introduction
============

Aging is associated with brain lesions or other abnormalities that may contribute to depression.[@b1-ndt-5-517]--[@b3-ndt-5-517] Among late-life depressive syndromes, late-onset depression has been conceptualized as a neurologic disease. This view has been supported by studies suggesting that late-onset depression is more often associated with cognitive impairment and neurologic comorbidity than early-onset depression.[@b4-ndt-5-517]--[@b7-ndt-5-517]

Comorbid neurologic disorders are not always clinically evident at the initial presentation of late-onset depression. Once developed, late-onset depression may have a slow or poor response to antidepressant treatment.[@b8-ndt-5-517],[@b9-ndt-5-517] Frontostriatal dysfunction may be one of the critical brain abnormalities contributing to late-life depression. Functional neuroimaging studies support this view as they have demonstrated abnormal metabolism in frontal regions and the caudate nucleus during depressive states.[@b10-ndt-5-517],[@b11-ndt-5-517] The consistency of findings implicating a dysfunction of frontostriatal pathways in geriatric depression has led to the depression--executive dysfunction (DED) syndrome hypothesis. This hypothesis postulates that in a subgroup of elderly patients with depression, frontostriatal dysfunction caused by cerebrovascular disease or other aging-related conditions is the main predisposing factor for depression.[@b9-ndt-5-517] It has been further hypothesized that DED syndrome has a distinct clinical presentation and poor long-term and short-term outcomes.[@b9-ndt-5-517]

Major depressive disorder is a highly prevalent disease in old age.[@b1-ndt-5-517]--[@b3-ndt-5-517] Between 1% and 4% of the elderly experience major depression and this prevalence increases to between 6% and 32% among older nursing home residents.[@b4-ndt-5-517] Though the elderly constitute a major subgroup, depression frequently affects the younger population as well. In this demographic, initial onset typically occurs in the late twenties, but the first episodes are not usually seen until after the age of 40 years.[@b6-ndt-5-517],[@b7-ndt-5-517]

Epidemiologically, about 40% of cases of major depression in old age are characterized by recurrent depressive episodes, whereas only 30% reflect late-onset depression. In some cases, recurrent and late-onset depression is difficult to distinguish clinically.[@b5-ndt-5-517]

Late-onset depression is a heterogeneous syndrome that includes patients with high medical burden and neurologic disorders that may or may not be clinically evident upon initial onset.[@b9-ndt-5-517]

Several studies on late-onset depression focus on major depression but not on other subtypes, such as dysthymia, minor depression, unspecified mood disorder, mood disorder related to medical conditions (Alzheimer disease or other dementias), subsyndromal depression, etc. In a recent study by Rapp and colleagues comparing late onset with recurrent depression, patients in both groups were diagnosed with major depression.[@b12-ndt-5-517]

We hypothesize that late-onset depression syndrome (which includes different subtypes of depression) could be consistent with initial symptoms of a degenerative brain process.

The aim of this paper is to study geriatric depression syndrome by contrasting cognitive differences, vascular comorbidity, and sociological risk factors in the following patient groups:

1.  Late-onset depressive patients with depressive episodes first appearing after the age of 60 years.

2.  Early-onset depressive patients with depressive episodes first appearing before the age of 60 years.

3.  Normal subjects (those lacking signs and symptoms of depression or cognitive impairment).

Inclusion criteria:

-   Patients who present depressive symptoms that are due to psychiatric causes or are related with dementia (Clinical Dementia Rating Scale 1 \[CDR\]).

-   Patients aged more than 55 years and less than 80 years.

-   Patients with Hamilton Depression Scale \>9 points.

Exclusion criteria

-   Patients with history of drug or alcohol abuse.

-   Patients with neurological diseases (except dementia).

-   Patients with moderate or severe dementia (CDR 2, or CDR 3).

-   Patients with schizophrenia or schizoaffective disorder.

Materials and methods
=====================

We recruited 76 patients from two Buenos Aires community-based outpatient hospitals, Hospital General Zubizarreta (public health system) and CEMIC University Hospital (private health system) that seek medical advice due to memory problems, all of whom exhibited depressive symptoms. In addition, we recruited 17 normal controls from the community.

Depressive patients were divided into two different groups: an early-onset depression group (39 patients) consisting of patients first exhibiting depressive episodes before the age of 60 years; and a late-onset depression group (37 patients), which included patients with depressive episodes starting after the age of 60 years.

All of them were assessed using a semistructured neuropsychiatric interview (administered by specialized psychiatrists and neurologists). Depressive syndromes were categorized into different diagnoses according to the *Diagnostic and Statistical Manual of Mental Disorders* (DSM IV)[@b13-ndt-5-517] and *International Codification of Diseases* (ICD 10) criteria[@b14-ndt-5-517] using schedules for clinical assessment in neuropsychiatry (SCAN 2.1).[@b15-ndt-5-517] Other psychiatric scales were utilized, including Hamilton Depression Scale[@b16-ndt-5-517] to evaluate level of depression and Hamilton Anxiety Scale[@b17-ndt-5-517] to determine level of anxiety.

Patients and normal controls were matched by age, education and overall cognitive status using the Mini-Mental State Examination (MMSE).[@b18-ndt-5-517]

We assessed vascular risk factors and comorbidities such as high blood pressure (HBP), high cholesterol level (HCL), heavy smoking, cerebrovascular disease (CVD), and heart diseases. Additionally, we evaluated sociological risk factors of depression, such as marital status (married or unmarried; unmarried patients included in this research paper were individuals that live alone and have no emotional support) and level of activity (active or passive).

In order to investigate the different cognitive profiles, each patient underwent an extensive neuropsychological battery to evaluate the following areas of cognitive ability:

-   Orientation: MMSE.[@b18-ndt-5-517]

-   Attention: Digit span (forward and backward);[@b19-ndt-5-517] Trail making test "A".[@b20-ndt-5-517]

-   Language: Boston Naming Test (BNT);[@b21-ndt-5-517] vocabulary;[@b22-ndt-5-517] semantic fluency (SF);[@b23-ndt-5-517] verbal intellectual quotient (IQ);[@b22-ndt-5-517] verbal fluency (VF).[@b23-ndt-5-517]

-   Memory: Signoret memory battery;[@b24-ndt-5-517] episodic memory: immediate logic memory (ILM), delayed logic memory (DLM); verbal serial learning (VSL), delayed serial memory (DSM), cued recall (CR), recognition (Recog). Buschke Selective Reminding Test, free recall (BSRT fr); Buschke Selective Reminding Test, cued recall (BSRT cr).[@b25-ndt-5-517]

-   Abstraction and reasoning: similarities and matrix reasoning.[@b22-ndt-5-517]

-   Visuospatial abilities: block design;[@b22-ndt-5-517] clock-drawing test.[@b26-ndt-5-517]

-   Executive functions: Trail Making Test "B";[@b20-ndt-5-517] VF.[@b23-ndt-5-517]

-   IQ: Wechsler Abbreviated Scale of Intelligence.[@b22-ndt-5-517]

Written informed consent was obtained from each subject after they had been given a full explanation of the study. The research was performed in accordance with the International Conference of Harmonization Good Clinical Practice guidelines, the latest revision of the 1964 Helsinki Declaration (as amended in Seoul 2008), and the Buenos Aires Government Health Authorities.

Data analysis
-------------

Data was analyzed using the Statistical Package for Social Sciences version 14[@b27-ndt-5-517] statistical package.

Demographic variables for both populations (patients and controls) as well as the results of neuro-psychiatric and neuropsychological general global tests were expressed as means, standard deviation and medians. Quantitative variables were compared using analysis of variance (ANOVA). Scheffe, Games--Howell, and Dunnet tests were also performed for multiple comparisons.

The relationship between qualitative variables was compared by the chi-squared test. Predictive factors for depression were analyzed using the odds ratio (OR) with 95% confidence intervals (95% CI).

Results
=======

Demographic data
----------------

The mean age of depression onset for the early-onset depressive group was 44.84 (standard deviation \[SD\], 12.72) and for the late-onset depressive group was 68.29 (SD, 7.98). There were no significant differences in age and education among the three groups. There were no statistically significant general cognitive differences (assessed by MMSE) between the two depressive patient groups (late- and early-onset), yet there was a significant variation in general cognitive level (assessed by MMSE) between depressive patients and normal controls (*P* \< 0.05) (see [Table 1](#t1-ndt-5-517){ref-type="table"}).

Neuropsychiatric diagnoses
--------------------------

Diagnostic algorithms were obtained from SCAN 2.1[@b15-ndt-5-517] according to DSM IV[@b13-ndt-5-517] and ICD 10 criteria.[@b14-ndt-5-517]

Patients with early-onset depression (N = 39) were diagnosed as follows: major depression (N = 20, seven of whom had bipolar disorder), dysthymia (N = 7), unspecified mood disorder (N = 3), mood disorder due to a medical condition (N = 6, three of whom had vascular dementia, two had Alzheimer dementia, and one had frontotemporal dementia).

Patients with late-onset depression (N = 37) were diagnosed as follows: dysthymia (N = 13), unspecified mood disorder (N = 11), major depression (N = 6), mood disorder due to a medical condition (N = 7; three of whom had vascular dementia and four had Alzheimer dementia).

Dementia diagnosis was made according to DSM IV,[@b13-ndt-5-517] NINCDS ADRDA (National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association)[@b28-ndt-5-517] criteria for probable Alzheimer disease, NINDS AIREN (National Institute of Neurological Disorders and Stroke/Association Internationale pour la Recherché et l'Enseignement en Neurosciences)[@b29-ndt-5-517] for vascular dementia and Lund and Manchester[@b30-ndt-5-517] criteria for frontotemporal dementia were used.

Neuropsychological assessment
-----------------------------

### Depressive patients versus normal controls

We found a wide variation in performance between depressive patients and normal controls in most cognitive functions: memory, attention, language, and executive functions (*P* \< 0.005) (see [Table 2](#t2-ndt-5-517){ref-type="table"}). The most significant differences were found in memory (*P* \< 0.0001): ILM, DLM, VSL, DSM (*P* \< 0.0001); SF (*P* \< 0.0001); VF; and digit-symbol (*P* \< 0.0001). As regards IQ, block design, performance IQ, and global IQ showed a significant variation (*P* \< 0.0001) between controls and depressive patients (see [Table 2](#t2-ndt-5-517){ref-type="table"}).

### Late- versus early-onset depression patients

Memory tests revealed significant differences in deferred serial memory (*P* \< 0.05), as late-onset depression patients scored lower and exhibited more severe impairment than early-onset depression patients. Moreover, late-onset patients were poorer performers in all memory domains (see [Table 2](#t2-ndt-5-517){ref-type="table"}).

Late-onset depressive patients had the worst performance in memory domain while early-onset depressive patients had poorer functioning in executive tests (see [Table 2](#t2-ndt-5-517){ref-type="table"}).

Neuropsychiatric scales
-----------------------

Both Hamilton Depression Scale and Hamilton Anxiety Scale scores did not significantly differ between the two groups. Both depressive groups displayed similar levels of anxiety and depression (see [Table 3](#t3-ndt-5-517){ref-type="table"}).

Depressive patients versus normal controls
------------------------------------------

### Vascular risk factors and comorbidity

There were nonsignificant differences between depressive patients and normal control groups with respect to vascular risk factors or comorbidities (see [Table 5](#t5-ndt-5-517){ref-type="table"}).

### Sociological risk factors for depression

Significant differences (*P* \< 0.05) were immediately apparent between depressive patients and normal controls in sociological risk factors, such as level of activity. The OR for developing depression was 6.02 in inactive patients (see [Table 4](#t4-ndt-5-517){ref-type="table"}).

Late- versus early-onset depression patients
--------------------------------------------

### Vascular risk factors and comorbidity

Significant differences were observed in cholesterol levels (*P* \< 0.05) between both depressive subtypes (early versus late); high cholesterol levels were especially prevalent in early-onset depressive patients (see [Table 5](#t5-ndt-5-517){ref-type="table"}).

### Sociological risk factors of depression

Significant differences (*P* \< 0.05) were shown in marital status between depressive groups, with a tendency towards lack of a stable emotional environment in early-onset patients (OR, 4.6). However, activity levels were similar in both groups (see [Table 5](#t5-ndt-5-517){ref-type="table"}).

As demented patients were present in both depression groups and we thought this might have some kind of implication on neuropsychological results, we excluded these patients (six early-onset depression patients with mood disorder due to a medical condition and seven late-onset depression patients with mood disorder due a to medical condition) and analyzed the new results.

Neuropsychological assessment
-----------------------------

### Depressive patients (without demented patients) versus normal controls

We found remarkable differences in performance between depressive patients and normal controls in most cognitive functions, particularly in memory, attention, language, and executive functions (*P* \< 0.005) (see [Table 6](#t6-ndt-5-517){ref-type="table"}). However, performance in visuospatial function (clock-drawing test) did not differ significantly. In spite of the fact that we removed demented patients from both groups, we observed a similar neuropsychological pattern to the one described above.

Early-onset depression: this group of depressive patients exhibited greater impairment in executive functions (VF) and attention (digit span forward and backward) than normal controls (see [Table 6](#t6-ndt-5-517){ref-type="table"}).

In late-onset depression patients, the memory domain was remarkably affected in comparison to normal controls (*P* \< 0.05) (see [Table 6](#t6-ndt-5-517){ref-type="table"}).

This contributes to support even more the fact that a different neuropsychological profile exists between late- and early-onset depression patients.

Discussion
==========

This study revealed that depressive patients underwent a general cognitive impairment, evidenced by differences in neuropsychological test performance relative to normal controls; performance differences were especially pronounced in memory domain and executive functions. Clinical studies have shown that diseases related to frontostriatal dysfunction predispose patients to depression and lead to executive function impairment in problem solving, sequencing, planning, organizing, and abstracting.[@b6-ndt-5-517],[@b31-ndt-5-517] Moreover, geriatric depression, even in the absence of a diagnosable neurological disease, is often accompanied by executive dysfunction.[@b7-ndt-5-517]

However, the most important trend that emerged in this study was that late-onset depression patients showed greater memory impairment than the early-onset group. In addition, early-onset patients had executive dysfunction. Moreover, late-onset depression patients showed greater impairment than early-onset depression patients. This demonstrates a different neuropsychological profile between these two groups of depressive patients.

Late-onset depression patients had greater impairment in episodic memory tests while early-onset depression patients had predominance of executive dysfunction. Episodic memory is subserved by the hippocampus while executive functions are related to frontostriatal and subcortical pathways. The first symptom observed in Alzheimer disease is impairment in episodic memory which is related to hippocampal atrophy, while in vascular cognitive impairment is evidenced through executive dysfunction.

What seems to differentiate this investigation from others is that in many studies late-onset depression is related to executive dysfunction probably due to cerebrovascular disease. However, in this research executive functioning is more related to early-onset depression than to late-onset depression.

Moreover, in this investigation we included different subtypes of depressive syndromes and found that the early-onset depression group was especially prone to major depression, while the late-onset group tended to exhibit unspecified mood disorder and dysthymia.

According to the previous findings, we could speculate that late-onset depression seems to be more related to a degenerative process, as episodic memory is the predominant affected. If this is so, some subtypes of late-onset depression, that maybe do not conform DSM IV criteria for major depression such as dysthymia or unspecified mood disorder, could be a clinical prodromal of Alzheimer disease. It is currently not clear whether prior depression is a true etiologic risk factor for dementia or rather represents a prodromal clinical manifestation of dementia neuropathology.[@b32-ndt-5-517]

The loss of hippocampal volume and memory function observed in some elders with late-life depression suggests the possibility that depression may be a predispositional risk factor for Alzheimer disease in particular. Indeed, lower hippocampal volumes independently predict subsequent Alzheimer disease in groups of mild cognitively impaired patients and cognitively normal elderly patients.[@b33-ndt-5-517] Likewise, deficits in verbal learning and memory, similar to those described in euthymic patients with history of major depression, also predict Alzheimer disease.[@b34-ndt-5-517]

Some structural magnetic resonance imaging (MRI) studies find that hippocampal atrophy is more strongly associated with late-onset than early-onset depression, suggesting that early Alzheimer disease-related pathophysiology could generate both hippocampal atrophy and depressive symptoms in some elderly persons.[@b35-ndt-5-517],[@b36-ndt-5-517] In addition, one of these studies failed to find a significant correlation between hippocampal volume and cortisol level among elders with depression. Furthermore, the late-life depression subjects showed persistent memory and cognitive impairment at six-month follow-up despite effective treatment of mood symptoms and normalization of cortisol levels.[@b36-ndt-5-517] All of these data are consistent with the idea that Alzheimer disease pathology is a major cause of hippocampal atrophy in some (but not all) individuals with late-life depression, and their depressive symptoms may represent prodromal Alzheimer disease.[@b32-ndt-5-517]

Butters and colleagues propose that depression alters an individual's risk of cognitive dysfunction, shortening the latent period between the development of Alzheimer disease neuropathology and the onset of clinical dementia, thus increasing the incidence and prevalence of Alzheimer disease among older adults with depression.

Many individuals with late-onset depression may be in the prodromal stage of Alzheimer disease, their hippocampus having already sustained substantial neuronal injury due to cumulative Alzheimer disease neuropathology.[@b32-ndt-5-517]

Late-onset depression and cognitive impairment usually go hand-in-hand, a trend that suggests a close association between the two.[@b37-ndt-5-517],[@b38-ndt-5-517] It is not known, however, which is causal.[@b38-ndt-5-517],[@b40-ndt-5-517]

Clinical practice and research evidence suggest that depression is a risk factor for cognitive decline in old age. It is quite difficult to affirm this association, because these studies are limited by the assumption that cognitive impairment is a result of depression itself, and fail to explore other causal relationships.[@b41-ndt-5-517]--[@b43-ndt-5-517] This association could not be confirmed by other investigations.[@b44-ndt-5-517]--[@b47-ndt-5-517]

Depression may very well be an early sign of, rather than an independent risk factor for, cognitive impairment, and as such, the temporal relationship between the two in old age remains unclear. In fact, the few studies that have undertaken both causal relationships have quite convincingly shown that depression in old age is a concomitant phenomenon of an already existing cognitive impairment rather than an independent risk factor.

Another important data observed in this study was that both groups scored similarly in Hamilton Depression Scale and Hamilton Anxiety Scale, which shows a degree of homogeneity in relation to the depressive symptoms.

No variable occurrences were observed in vascular risk factors and comorbidity between depressives and normal controls. However, differences were evident between depressive groups as early-onset depressives exhibited high cholesterol levels.

As regards to sociological variables, inactive patients were much more likely to develop depression than those who were engaged in regular activity (OR, 6.02). Marital status played an important role when looking at depression groups. Late-onset depression patients were more frequently married while early-onset depressives were more often unmarried (which in our investigation was related to a lack of emotional support).

Prospective studies reveal a higher incidence of depression in women than in men.[@b48-ndt-5-517] Other potential risk factors include marital status,[@b49-ndt-5-517]--[@b51-ndt-5-517] concomitant diseases,[@b49-ndt-5-517] low education, functional disability (which can correlate with inactivity),[@b52-ndt-5-517] and alcohol abuse. Social isolation, physical inactivity, and lack of leisure cognitive activity may result in lowered reserve and therefore confer additional risk for exhibiting clinical symptoms of dementia.[@b32-ndt-5-517]

Conclusion
==========

According to the results of the present study, depressive patients (both early- and late-onset) had significantly lower performances, in comparison to normal controls, in all neuropsychological tests. Furthermore, the late-onset depression group had more cognitive impairment than the early-onset depression group, in spite of the fact that in both groups' patients with dementia were present in similar number. These results might support the theory that cognitive decline causes late-onset depression, which may be correlated with a degenerative biological brain change.

Unspecified mood disorder was significantly prevalent in the late-onset depressive group. According to DSM IV[@b13-ndt-5-517] and ICD 10[@b14-ndt-5-517] classifications, this diagnosis is made when mood disorders do not meet any criteria for depressive disorders, so it should be considered when evaluating late-onset depression.

Inactivity and lack of social interaction are examples of severe life stress events that may lead to increased depression in individuals.

Artero and Ritchie[@b53-ndt-5-517] examined the evidence for a separate nosological entity of late-onset depressive episodes. Their studies showed that late-onset depression is likely due to various underlying causes and should not be classified as an independent disease entity. van den Berg and colleagues[@b54-ndt-5-517] divided late-onset depression patients into two subgroups with distinct etiological pathways: one through the experience of severe life stress, and the other through degenerative biological brain changes.

The literature on depression and dementia has always been somewhat contradictory. There are three main hypotheses[@b55-ndt-5-517] that attempt to explain the association: (1) depression may be a psychological reaction to eroding cognitive capacities early in the course of dementia; (2) a common underlying central nervous system disorder may be the cause of depression, as well as cognitive decline in elderly persons; it has been shown that elderly depressed people have more frequent and more severe white matter and other subcortical abnormalities on brain magnetic resonance imaging; (3) depression may be associated with high levels of cortisol, which can lead to neuronal death and deregulation of the hypothalamic-pituitary adrenal axis resulting in hippocampal atrophy and cognitive decline. Several studies have found links between late-onset depression and Alzheimer's disease.[@b56-ndt-5-517]--[@b59-ndt-5-517]

Depression is a mental disease that affects not only the psychological well-being of a patient (by causing mood disorders), but also his/her neuropsychological profile (through cognitive impairment). Geriatric depression may be a sign of brain degeneration and the initial symptom of a dementing disorder. It is important to consider this in patients whose depressive symptoms begin after the age of 60 years.
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###### 

Demographic data

                              Early-onset depression   Late-onset depression   Normal controls   *P* value
  --------------------------- ------------------------ ----------------------- ----------------- -------------------------------------------------
  Age (years)                 65.4 ± 7.8               69.4 ±7.6               65.4 ±6.1         NS
  Educational level (years)   9.8 ± 4.3                9.8 ±4.3                12.5 ±3.8         NS
  MMSE                        26.4 ± 3.5               25.8 ±4.5               29.0 ±1.0         0.015[\*](#tfn2-ndt-5-517){ref-type="table-fn"}

**Notes:** Values expressed are mean ± standard deviation.

Significant differences: *P* \< 0.05. NS: nonsignificant differences (*P* \> 0.05).

**Abbreviation:** MMSE, Mini-Mental State Examination.

###### 

Neuropsychological assessment

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Tests                                  Early-onset\        Late-onset\         Normal controls\   *P* value
                                         depression N = 39   depression N = 37   N = 17             
  -------------------------------------- ------------------- ------------------- ------------------ -------------------------------------------------------------------------------------------------------------------------------------
  **Memory**                                                                                        

  Immediate logic memory                 5.0 ± 2.4           4.3 ± 2.5           7.9 ± 1.8          0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Delayed logic memory                   4.6 ± 2.7           3.7 ± 2.7           7.5 ± 2.0          0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Verbal serial learning                 7.4 ± 2.4           6.5 ± 2.4           9.7 ± 1.6          0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Delayed serial memory                  5.8 ± 2.7           4.0 ± 3.1           8.4 ± 1.9          0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[&](#tfn6-ndt-5-517){ref-type="table-fn"}

  Cued recall                            8.6 ± 3.2           7.1 ± 3.6           11.2 ± 0.9         0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Recognition                            10.3 ± 2.3          9.9 ± 2.9           11.7 ± 0.4         0.035[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Buschke memory battery (free recall)   6.5 ± 1.9           5.2 ± 2.8           7.4 ± 1.1          0.005[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Buschke memory battery (cued recall)   7.0 ± 1.4           5.9 ± 2.5           7.6 ± 1.0          0.013[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  **Language**                                                                                      

  Boston Naming Test                     43.2 ± 8.2          43.9 ± 9.3          52.9 ± 4.0         0.001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Semantic fluency                       12.4 ± 4.0          13.5 ± 5.2          20.1 ± 4.7         0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Verbal fluency                         9.6 ± 4.6           11.4 ± 4.8          15.4 ± 3.4         0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Vocabulary                             44.3 ± 12.6         47.5 ± 11.7         51.3 ± 19.6        Ns

  **Attention**                                                                                     

  Trail Making Test "A"                  82.3 ± 57.6         82.0 ± 59.6         50.8 ±18.1         0.001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Digit span (forward)                   5.0 ± 1.0           5.3 ± 1.2           6.1 ± 1.0          0.002[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Digit--Symbol                          23.4 ± 11.5         25.6 ± 15.7         45.0 ± 10.6        0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Digit span (backward)                  3.5 ± 1.0           3.5 ± 0.9           4.5 ± 1.3          0.004[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  **Executive functions**                                                                           

  Trail Making Test "B"                  239.3 ± 160.4       231.8 ± 148.8       115.4 ± 43.7       0.009[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Verbal fluency                         9.6 ± 4.6           11.3 ± 4.8          15,4 ± 3,4         0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  **Visuospatial abilities**                                                                        

  Clock-drawing test                     5.2 ± 2.3           5.2 ± 2.3           6.6 ± 0.6          0.045[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Block design                           41.4 ± 7.5          44.8 ± 11.0         58.2 ± 11.6        0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  **Abstraction and logic reasoning**                                                               

  Similarities                           42.0 ± 11.0         47.4 ± 10.3         52.0 ± 8.2         0.021[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Matrix reasoning                       40.0 ± 9.5          42.3 ± 13.0         55.0 ± 6.4         0.003[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  **Intellectual quotient**                                                                         

  Verbal IQ                              90.5 ± 14.4         95.6 ± 16.8         107.4 ± 11.6       0.014[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Performance IQ                         86.4 ± 11.3         91.3 ± 15.5         110.4 ± 8.7        0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}

  Global IQ                              87.5 ± 23.4         93.7 ± 14.0         110.5 ± 8.3        0.0001[\*](#tfn5-ndt-5-517){ref-type="table-fn"}[\*](#tfn5-ndt-5-517){ref-type="table-fn"}
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Neuropsychological battery values expressed are mean + standard deviation.

Significant differences: *P* \< 0.05 between normal and (early- and late-onset) depression patients.

Significant differences between early- and late-onset depression patients.

**Abbreviations:** IQ, intelligence quotient; NS, nonsignificant differences (*P* \> 0.05).

###### 

Neuropsychiatric assessment

  ---------------------------------------------------------------------
  Neuropsychiatric assesment   Early-onset\   Late-onset\   *P* value
                               depression\    depression\   
                               N = 39         N = 37        
  ---------------------------- -------------- ------------- -----------
  Hamilton Anxiety Scale       17.5 ± 8.0     14.1 ± 5.7    NS

  Hamilton Depression Scale    17.1.4 ± 7.1   15.5 ± 4.4    NS
  ---------------------------------------------------------------------

**Note:** Values expressed are mean + standard deviation.

**Abbreviation:** NS, nonsignificant differences (*P* \> 0.05).

###### 

Risk factors. Depressive patients versus normal controls

  Risk factors                          Depressives   Controls   *P* value[\*](#tfn10-ndt-5-517){ref-type="table-fn"}   OR (CI)
  ------------------------------------- ------------- ---------- ------------------------------------------------------ --------------
  Level of activity (Passive/Active)    (43/23)       (4/13)     0.005                                                  6.07 (2--20)
  Marital status (Married/Lonely)       (25/42)       (3/12)     NS                                                     
  High blood pressure level (Yes, No)   (33/42)       (4/13)     NS                                                     
  Diabetes (Yes, No)                    (7/68)        (0/17)     NS                                                     
  High cholesterol level (Yes, No)      (36/39)       (4/13)     NS                                                     
  Heart disease (Yes, No)               (24/51)       (1/16)     NS                                                     
  Cerebrovascular disease (Yes, No)     (9/66)        (1/16)     NS                                                     
  Heavy smoking (Yes, No)               (23/52)       (7/10)     NS                                                     

**Note:** Chi-squared test.

**Abbreviations:** CI, confidence interval; OR, odds ratio.

###### 

Risk factors in early-onset depression versus late-onset depression

  Risk factors                          Early-onset   Late-onset   *P* value\*   OR (CI)
  ------------------------------------- ------------- ------------ ------------- ---------------
  Level of activity (Passive/Active)    (22/13)       (21/10)      NS            
  Marital status (Married/Lonely)       (19/17)       (25/6)       0.01          4.6 (1.5--14)
  High blood pressure level (Yes, No)   (14/24)       (19/18)      NS            
  Diabetes (Yes, No)                    (6/32)        (1/36)       NS            
  High cholesterol level (Yes, No)      (23/15)       (13/24)      0.028         NS
  Heart disease (Yes, No)               (8/30)        (16/21)      NS            
  Cerebrovascular disease (Yes, No)     (4/34)        (5/32)       NS            
  Tobacco abuse (Yes, No)               (12/26)       (11/26)      NS            

**Abbreviations:** CI, confidence interval; NS, nonsignificant; OR, odds ratio.

###### 

Neuropsychological assessment

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Tests                                       Early-onset\        Late-onset\         Normal controls\   *P* value
                                              depression N = 32   depression N = 30   N = 17             
  ------------------------------------------- ------------------- ------------------- ------------------ ---------------------------------------------------
  **Memory**                                                                                             

  Immediate logic memory                      5.5 ± 2.3           4.9 ± 2.2           7.9 ± 1.8          0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Delayed logic memory                        5.1 ± 2.6           4.3 ± 2.5           7.5 ± 2.0          0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Verbal serial learning                      7.5 ± 2.3           7.0 ± 2.2           9.7 ± 1.6          0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Delayed serial memory                       6.0 ± 2.5           4.6 ± 3.0           8.4 ± 1.9          0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Cued recall                                 8.8 ± 3.2           7.7 ± 3.3           11.2 ± 0.9         0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Recognition                                 10.3 ± 2.4          10.6 ± 1.8          11.7 ± 0.4         0.03[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Buschke Memory battery (Immediate memory)   6.8 ± 1.8           5.9 ± 2.4           7.4 ± 1.1          0.036[\$](#tfn16-ndt-5-517){ref-type="table-fn"}

  Buschke Memory battery (Cued memory)        7.3 ± 1.1           6.5 ± 1.9           7.6 ± 1.0          Ns

  **Language**                                                                                           

  Boston Naming Test                          44.5 ± 7.7          45.7 ± 7.5          52.9 ± 4.0         0.001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Semantic Fluency                            13.1 ± 4.0          14.6 ± 4.9          20.1 ± 4.7         0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Verbal Fluency                              10.4 ± 4.4          12.5 ± 4.5          15.4 ± 3.4         0.001[\#](#tfn15-ndt-5-517){ref-type="table-fn"}

  Vocabulary                                  46.7 ± 11.9         49.5 ± 10.8         51.3 ± 19.6        Ns

  **Attention**                                                                                          

  Trail Making Test "A"                       64.4 ± 29.3         74.3 ± 50.6         50.8 ±18.1         Ns

  Digit Span (forward)                        5.1 ± 1.0           5.3 ± 1.3           6.1 ± 1.0          0.010[\#](#tfn15-ndt-5-517){ref-type="table-fn"}

  Digit Span (backward)                       3.5 ± 1.0           3.7 ± 0.8           4.5 ± 1.3          0.032[\#](#tfn15-ndt-5-517){ref-type="table-fn"}

  Digit--Symbol                               27.0 ± 9.9          28.6 ± 15.3         45.0 ± 10.6        0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  **Executive functions**                                                                                

  Trail Making Test "B"                       209.2 ± 144.5       220.7 ± 142         115.4 ± 43.7       0.023[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Verbal fluency                              10.4 ± 4.4          12.57 ± 4.6         15,4 ± 3,4         0.001[\#](#tfn15-ndt-5-517){ref-type="table-fn"}

  **Visuospatial abilities**                                                                             

  Clock-drawing test                          5.56 ± 2.1          5.7 ± 1.7           6.6 ± 0.6          Ns

  Block design                                42.7 ± 7.5          46.3 ± 11.3         58.2 ± 11.6        0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  **Abstraction and logic reasoning**                                                                    

  Similarities                                44.0 ± 10.9         48.1 ± 10.6         52.0 ± 8.2         Ns

  Matrix reasoning                            40.5 ± 9.8          43.2 ± 14.1         55.0 ± 6.4         0.005[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  **Intellectual quotient**                                                                              

  Verbal IQ                                   93.6 ± 13.6         98.4 ± 15.2         107.4 ± 11.6       0.03[\#](#tfn15-ndt-5-517){ref-type="table-fn"}

  Performance IQ                              87.8 ± 11.5         93.4 ± 16.2         110.4 ± 8.7        0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}

  Global IQ                                   89.9 ± 11.8         96.1 ± 13.9         110.5 ± 8.3        0.0001[\*](#tfn14-ndt-5-517){ref-type="table-fn"}
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** Values expressed are mean + standard deviation.

Significant differences: *P* \< 0.05 between normal and (early- and late-onset) depression patients.

Significant differences between early-onset depression patients and normal controls.

Significant differences between late-onset depression patients and normal controls.

**Abbreviations:** NS, nonsignificant differences (*P* \> 0.05); IQ, intelligence quotient.
